Introduction: Epistaxis is a widespread distressing complaint in otolaryngology. Spontaneous pediatric nosebleeds are a major source of distress to patients and their caregivers due to their repetitive and idiopathic nature. Apart from conservative measures, chemical cauterization is a main pillar of treatment due to being minimally invasive and highly efficient. Silver nitrate is the main agent used for epistaxis control. Trichloroacetic acid "TCA" is used in a widely used cauterization agent. There are no enough previous studies assessing TCA efficacy in managing idiopathic epistaxis.
Purpose: To compare the outcomes of TCA to silver nitrate chemical cauterization in managing pediatric epistaxis.
Method: Prospective randomized double blinded clinical trial, 160 pediatric patients with idiopathic anterior epistaxis were divided into 2 groups in a ratio 1:1 where group (A) treated with silver nitrate 15 % after local anesthesia application (B) were treated with 15% TCA locally applied to the bleeder. Patients were assessed upon recurrence, pain and crusting during and 3 months after completing their treatment protocol.
Results: Recurrence of epistaxis showed a non-significant difference between the two groups.The pain was significantly higher in TCA group (P=0.006*). Crusting was slightly higher in TCA group, but it was statistically non-significant.
Conclusion: TCA is considered an effective chemical cautery agent for the management of childhood epistaxis with comparable results to silver nitrate agent.
No
Auf unserem Internetauftritt verwenden wir Cookies. Bei Cookies handelt es sich um kleine (Text-)Dateien, die auf Ihrem Endgerät (z.B. Smartphone, Notebook, Tablet, PC) angelegt und gespeichert werden. Einige dieser Cookies sind technisch notwendig um die Webseite zu betreiben, andere Cookies dienen dazu die Funktionalität der Webseite zu erweitern oder zu Marketingzwecken. Abgesehen von den technisch notwendigen Cookies, steht es Ihnen frei Cookies beim Besuch unserer Webseite zuzulassen oder nicht.